Evidence-based·Updated November 16, 2026·How we grade evidence

Alprazolam

MedicationBenzodiazepine (prescription)

Alprazolam is a fast-acting benzodiazepine for short-term treatment of generalized anxiety disorder and for panic disorder. Short trials show it works better than placebo, with relief of panic within the first one or two weeks. The boxed warning covers opioids, abuse and addiction, and dependence with dangerous withdrawal; alcohol, kava and cannabis can add to its sedation, and valerian is best treated the same way although its evidence is weaker.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with generalized anxiety disorder needing short-term relief, or with panic disorder, treated by a prescriber

Common dosing range

Set by a prescriber. For GAD the label starts at 0.25 to 0.5 mg three times daily, up to a maximum of 4 mg per day; for panic disorder it starts at 0.5 mg three times daily (Xanax XR 0.5 to 1 mg once daily, usual range 3 to 6 mg). Older adults and people with liver impairment start at 0.25 mg two or three times daily

When to expect effects

Blood levels peak in 1 to 2 hours; in a large panic disorder trial, improvement appeared by weeks 1 and 2

Watch out for

Boxed warnings: profound sedation, slowed breathing, coma and death with opioids; abuse, misuse and addiction, which can lead to overdose or death; and physical dependence, with withdrawal reactions that can be life-threatening after abrupt stopping or rapid dose reduction. Alcohol and other sedatives add to its effects, and strong CYP3A blockers such as ketoconazole and itraconazole are contraindicated.

What is it

Alprazolam is a prescription benzodiazepine and a Schedule IV controlled substance, sold as Xanax, Xanax XR and generic tablets. The FDA label approves immediate-release Xanax for the acute treatment of generalized anxiety disorder (GAD) in adults and for panic disorder with or without agoraphobia in adults; Xanax XR, taken once daily, is approved for panic disorder. Alprazolam carries the boxed warning shared by all benzodiazepines: combining it with opioids may cause profound sedation, slowed breathing, coma and death; it carries risks of abuse, misuse and addiction; and continued use can lead to physical dependence, with withdrawal reactions that can be life-threatening if it is stopped suddenly. Because it is a sedative, other sedating products, including alcohol, kava, valerian and cannabis, are the main supplement and drink concerns.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have panic disorder or generalized anxiety disorder and your prescriber recommends short-term alprazolam, often while other treatments take effect (with a prescriber)
You and your prescriber have agreed on the lowest effective dose, regular reviews and a plan for eventually tapering (with a prescriber)
You do not drink alcohol and do not take opioids, or your prescriber has weighed those risks with you (with a prescriber)

Probably skip if…

You take an opioid pain medicine, unless your prescriber decides other options are inadequate: the boxed warning covers this combination
You take ketoconazole, itraconazole or another strong CYP3A blocker (other than ritonavir): the label says not to use alprazolam
You want to keep using kava, valerian, cannabis or other sedating products alongside it: discuss these with your prescriber first
You want a long-term treatment for panic disorder: a Cochrane review notes that guidelines recommend SSRI antidepressants first because benzodiazepines carry dependence and withdrawal risks

Evidence at a glance

panic disorder (short-term treatment)

Good Evidence
Effect
Better than placebo on most measures at 8 weeks, with faster onset than imipramine
Best fit
Adults with panic disorder who need relief quickly
Time
Improvement by weeks 1 to 2

panic disorder (pooled trials)

Limited Evidence
Effect
Moderate in short trials; risk ratio 1.65 for response vs placebo
Best fit
Adults with panic disorder in short-term treatment
Time
Short-term trials of weeks

generalized anxiety disorder (short-term)

Limited Evidence
Effect
Small to moderate; 2.5 points more improvement on the Hamilton anxiety scale than placebo
Best fit
Adults with generalized anxiety disorder needing short-term relief
Time
Psychic anxiety improved by week 1

Evidence for 3 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

panic disorder (short-term treatment)

Disease adjunct
Good Evidence

The Cross-National Collaborative Panic Study (Phase Two) randomized 1,168 people with panic disorder at 12 centers to alprazolam, the antidepressant imipramine or placebo for 8 weeks. Improvement appeared with alprazolam by weeks 1 and 2 and with imipramine by week 4. By week 8 the two drugs had similar effects, and both were better than placebo on most outcome measures. The trial did not test long-term use, dependence or what happens after stopping.

Effect size
Better than placebo on most measures at 8 weeks, with faster onset than imipramine
Time to effect
Improvement by weeks 1 to 2
Best fit
Adults with panic disorder who need relief quickly
Less likely
People needing long-term treatment, which this 8-week trial did not test

Bottom line: In a large 8-week trial, alprazolam relieved panic disorder sooner than imipramine and both beat placebo.

panic disorder (pooled trials)

Disease adjunct
Limited Evidence

A 2019 Cochrane review of 24 trials with 4,233 participants found benzodiazepines more likely than placebo to bring a treatment response (risk ratio 1.65; about 4 people treated for one extra response) and remission, with fewer dropouts overall but more dropouts due to side effects (risk ratio 1.58). The evidence was low quality, and the trials were short and did not examine dependence or withdrawal. A 2023 Cochrane network meta-analysis of 70 trials ranked alprazolam among the most effective medicines for response and for reducing the number of panic attacks, again with low-quality evidence for benzodiazepines.

Effect size
Moderate in short trials; risk ratio 1.65 for response vs placebo
Time to effect
Short-term trials of weeks
Best fit
Adults with panic disorder in short-term treatment
Less likely
People wanting long-term treatment; guidelines prefer SSRIs because of dependence risk

Bottom line: Pooled short trials suggest benzodiazepines, including alprazolam, help panic disorder, but the evidence is low quality.

Evidence is mixed

The reviewers note that guidelines recommend SSRI antidepressants first for panic disorder because of benzodiazepine dependence and withdrawal, which the pooled trials did not measure.

generalized anxiety disorder (short-term)

Disease adjunct
Limited Evidence

In a 4-week randomized trial in outpatients with generalized anxiety disorder (Hamilton anxiety score 20 or higher), alprazolam reduced the Hamilton anxiety score by 10.9 points versus 8.4 with placebo. It improved psychic anxiety symptoms from week 1 but not somatic (physical) anxiety symptoms. A 2019 network meta-analysis of 89 trials with 25,441 patients found benzodiazepines effective for generalized anxiety disorder but poorly tolerated compared with placebo.

Effect size
Small to moderate; 2.5 points more improvement on the Hamilton anxiety scale than placebo
Time to effect
Psychic anxiety improved by week 1
Best fit
Adults with generalized anxiety disorder needing short-term relief
Less likely
People whose anxiety is mainly physical symptoms, which did not improve significantly in the trial

Bottom line: Alprazolam eases generalized anxiety in the short term, but side effects make it less well tolerated than several alternatives.

How it works

Alprazolam binds the benzodiazepine site of the GABA-A receptor in the brain and strengthens the calming effect of GABA, the brain's main inhibitory signal. This reduces anxiety and panic but also causes drowsiness, slower reactions and poorer coordination. Blood levels peak 1 to 2 hours after a dose, and the label gives an average half-life of about 11.2 hours in healthy adults (range 6.3 to 26.9 hours), and about 16.3 hours in healthy older adults and 19.7 hours in people with alcoholic liver disease. Two features shape its interactions. First, anything else that depresses the brain adds to its effect: alcohol, opioids, sleep medicines, sedating antihistamines and sedating herbs. Second, the liver enzyme CYP3A clears alprazolam, so strong blockers of this enzyme, such as ketoconazole and itraconazole, raised alprazolam levels about 4-fold and 2.7-fold and are contraindicated, while enzyme inducers lower its levels.

How to take it

1. Typical dose
Your prescriber sets and adjusts the dose. Labeled adult starting doses: for generalized anxiety disorder, 0.25 to 0.5 mg three times daily, adjusted every 3 to 4 days; for panic disorder, 0.5 mg three times daily, raised every 3 to 4 days by no more than 1 mg per day. Xanax XR for panic disorder starts at 0.5 to 1 mg once daily, preferably in the morning. Older adults and people with liver impairment start at 0.25 mg two or three times daily (Xanax XR 0.5 mg once daily). With ritonavir, the label tells prescribers to use half the recommended dose when the two are started together, then return to the target dose after 10 to 14 days.
2. Higher studied dose
For GAD the label maximum is 4 mg per day in divided doses. Panic disorder trials used 1 to 10 mg per day, with a mean of about 5 to 6 mg; the label advises periodic reassessment and consideration of a lower dose above 4 mg per day. The usual Xanax XR range is 3 to 6 mg once daily.
3. Timing
Immediate-release tablets are usually taken three times a day; Xanax XR once a day, preferably in the morning, swallowed whole
4. With food
The Xanax label gives no food instructions for the immediate-release tablets. For Xanax XR, a high-fat meal raised the peak level by about 25% but did not change total exposure.
5. Split dosing
Immediate-release doses are divided through the day; Xanax XR is a single daily dose
6. How long to try
As short as practical, with the need reviewed often. The label says continued use can cause physical dependence and that abrupt stopping or rapid dose reduction can cause life-threatening withdrawal reactions, so any reduction is a gradual taper planned with your prescriber (the label suggests no more than 0.5 mg every 3 days, sometimes slower).

What to track

Drowsiness, unsteadiness or slurred speech, especially in older adults and after any new medicine or supplement
Breathing: slow or shallow breathing or being hard to wake, especially with opioids or alcohol (call emergency services)
Needing more alprazolam than prescribed, or anxiety returning between doses, which you should tell your prescriber about
Low mood or thoughts of self-harm, which benzodiazepines can worsen in people with depression
Do not drive or operate machinery until you know how alprazolam affects you

Bottom line: A prescriber sets the dose and any taper; keep alcohol and sedating herbs out of the picture unless your prescriber agrees.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Drowsiness (41% vs 22% on placebo in GAD trials)Light-headedness and dizzinessImpaired coordinationSlurred speechLow blood pressureIncreased libidoDry mouth

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the label says newborns of mothers who used benzodiazepines late in pregnancy have had sedation (breathing problems, sluggishness, low muscle tone) and withdrawal symptoms, and that published observational studies do not report a clear link between benzodiazepines and major birth defects. Newborns exposed during pregnancy or labor should be watched for sedation, breathing problems, low muscle tone, feeding problems and withdrawal. A pregnancy registry for psychiatric medicines collects outcomes. Breastfeeding: alprazolam has been found in breast milk, and there are reports of sedation, poor feeding and poor weight gain in infants exposed to benzodiazepines through milk. Because of the risk of sedation and withdrawal in the infant, the label advises that breastfeeding is not recommended during treatment.

Interactions

AlcoholCritical

The Xanax label says alprazolam adds to the effects of other central nervous system depressants, including ethanol, and its Medication Guide warns that taking benzodiazepines with alcohol can cause severe drowsiness, breathing problems, coma and death. Do not drink while taking alprazolam unless your prescriber has told you otherwise, and call emergency services for anyone who is hard to wake or breathing slowly.

Opioids (oxycodone, hydrocodone, tramadol, codeine, morphine, fentanyl, methadone, buprenorphine)Critical

Boxed warning: benzodiazepines with opioids may cause profound sedation, respiratory depression, coma and death. In a study of US veterans on opioid pain medicines, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death. The label limits the combination to people whose other options are inadequate, at the lowest doses for the shortest time.

Strong CYP3A blockers (ketoconazole, itraconazole, clarithromycin) and other CYP3A blockers (nefazodone, fluvoxamine, cimetidine, erythromycin)Critical

Strong CYP3A blockers are contraindicated with alprazolam, except ritonavir, which needs a dose adjustment; ketoconazole and itraconazole raised alprazolam levels 3.98-fold and 2.70-fold. The label says to avoid moderate or weak blockers or consider a lower alprazolam dose. Tell every prescriber and pharmacist that you take alprazolam.

Kava (Piper methysticum)High

Kavain, a main kava compound, strengthens GABA-A receptors, the same calming system alprazolam acts on, and a systematic review of herb-drug interactions reports a semicomatose state when kava was taken with alprazolam. Kava has also caused liver injury in some people. Avoid combining them, and talk to your prescriber before using any calming herbal product; the label warns that stopping alprazolam suddenly can cause dangerous withdrawal, so any change goes through your prescriber.

Cannabis and THC productsHigh

Cannabis can cause sedation and poor coordination, and the Xanax label says alprazolam adds to the effects of other drugs that depress the brain. The label for dronabinol, a prescription form of THC, also lists benzodiazepines among drugs that can add to its sedation and its effect on driving. Direct evidence for THC with alprazolam is limited: in a small lab study in 10 cannabis users, diazepam changed the effects of oral THC very little, while a 2024 systematic review found that CBD raised levels of the active form of clobazam, another benzodiazepine, and caused more sedation. Do not drive after using both, and tell your prescriber about any cannabis use.

Valerian (including valerian tea)Moderate

Valerenic acid from valerian enhances GABA-A receptors, and a case report described tremor, dizziness and muscle fatigue in a man taking lorazepam with valerian and passionflower. In 12 healthy volunteers, 14 nights of valerian raised the peak level of alprazolam from 25 to 31 ng/ml without changing overall exposure, and a review found no clinically relevant valerian interactions. Treat valerian as a second sedative and use it only if your prescriber agrees.

MelatoninModerate

Both promote sleepiness, so together they may add to drowsiness and slower reactions, especially in older adults. In a randomized trial of 80 adults before surgery, a single dose of alprazolam plus melatonin relieved anxiety better than either alone without worsening sedation scores or memory effects, but nightly use together has not been studied. Tell your prescriber if you use melatonin and avoid driving until you know how the combination affects you.

St. John's wortModerate

St. John's wort speeds up CYP3A4, the enzyme that clears alprazolam. In 12 healthy volunteers, 14 days of a standard extract halved alprazolam exposure, which could weaken its effect, while a low-hyperforin extract made little difference. Tell your prescriber before starting or stopping the herb, since levels can rise again after stopping, and do not change your alprazolam dose on your own.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (4)

+ alcohol

critical

Alcohol and alprazolam (Xanax) both depress the central nervous system by enhancing GABA-A receptor activity. Taken together they produce additive, and sometimes synergistic, sedation, slowed breathing, and impaired coordination, which substantially raises the risk of overdose and death even when neither is taken in a large amount.

+ kava

high

Kava's active compounds (kavalactones) act on the brain's GABA-A receptor, the same inhibitory system that alprazolam, a benzodiazepine, enhances. Taken together they cause additive central nervous system depression. A published case report describes a man who became semi-comatose after combining kava with alprazolam. Kava also carries an independently documented risk of liver injury.

+ melatonin

moderate

Alprazolam and melatonin both promote sleep and can produce additive sedation, so taking them together may increase drowsiness, slow reaction time, and carry over into next-day grogginess. The combination is generally manageable but warrants your prescriber's awareness, especially for older adults and anyone who drives in the morning.

+ st. john's wort

moderate

St. John's wort speeds up CYP3A4, the liver enzyme that clears alprazolam (Xanax), which can lower alprazolam levels and weaken its effect. In 12 healthy volunteers, 14 days of St. John's wort halved alprazolam exposure and cut its half-life from about 12 to 6 hours. The effect depends on the product: a low-hyperforin extract tested in 28 volunteers, and a smaller study in 7 volunteers, showed no meaningful change. The Xanax label advises caution with CYP3A inducers but does not name St. John's wort, and no study measured anxiety control in patients.

See all 4 Alprazolam interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Dispensed only on prescription by a licensed pharmacy; alprazolam is a Schedule IV controlled substance
Immediate-release tablets of 0.25, 0.5, 1 and 2 mg (Xanax and generics) and once-daily extended-release Xanax XR tablets, which are swallowed whole
Comes with an FDA Medication Guide that warns about opioids, alcohol and other sedating products
Store it securely; the label notes that selling or giving it away is against the law

Be skeptical of…

Online sellers or social media offering "Xanax" without a prescription or outside a licensed pharmacy
"Natural Xanax" herbal blends, such as kava or valerian products, marketed as safe to take with a benzodiazepine
Advice to stop alprazolam suddenly or replace it with a supplement on your own: the label warns abrupt stopping can cause life-threatening withdrawal

Frequently asked questions

Can I take kava or valerian with alprazolam?⌄

Not without your prescriber. Both herbs act on the same GABA-A calming system, and kava with alprazolam has been linked to a semicomatose state. Valerian's interaction evidence is weaker, but it is still best treated as a second sedative.

Can I take melatonin with Xanax?⌄

Tell your prescriber first. Both cause sleepiness. In a trial of single doses before surgery, adding melatonin to alprazolam did not worsen sedation, but regular nightly use together has not been studied.

Can I drink alcohol on alprazolam?⌄

No. The label says alprazolam adds to the effects of alcohol, and its Medication Guide warns the combination can cause severe drowsiness, breathing problems, coma and death.

Is it safe to use cannabis while taking alprazolam?⌄

It is best avoided. Both can cause sedation and poor coordination, so do not drive after using both. Direct studies of THC with alprazolam are limited; tell your prescriber about any cannabis or CBD use.

Why can't I just stop taking alprazolam?⌄

The boxed warning says abrupt stopping or a rapid dose reduction after continued use can cause withdrawal reactions, including seizures, that can be life-threatening. Your prescriber can plan a gradual taper if a change is needed.

References by claim

panic disorder (short-term treatment)

PMID 1540759 · PubMed (1992) link

panic disorder (pooled trials)

Breilmann et al., 2019 · PMC (2019) link

Guaiana et al., 2023 · PMC (2023) link

generalized anxiety disorder (short-term)

Rickels et al., 2005 · PubMed (2005) link

Slee et al., 2019 · PubMed (2019) link

Safety

Xanax (alprazolam) prescribing information and Medication Guide · DailyMed (FDA label) link

Interaction: Kava (Piper methysticum)

Chua et al., 2016 · PMC (2016) link

Izzo et al., 2001 · PubMed (2001) link

Almeida et al., 1996 · PubMed (1996) link

Teschke et al., 2010 · PubMed (2010) link

Interaction: Cannabis and THC products

Syndros (dronabinol) prescribing information · DailyMed (FDA label) link

Ho et al., 2024 · PMC (2024) link

Lile et al., 2014 · PMC (2014) link

Interaction: Valerian (including valerian tea)

Khom et al., 2007 · PubMed (2007) link

Carrasco et al., 2009 · PubMed (2009) link

Donovan et al., 2004 · PubMed (2004) link

Kelber et al., 2014 · PMC (2014) link

Interaction: Melatonin

Pokharel et al., 2014 · PMC (2014) link

Interaction: Opioids (oxycodone, hydrocodone, tramadol, codeine, morphine, fentanyl, methadone, buprenorphine)

Park et al., 2015 · PMC (2015) link

Interaction: St. John's wort

Markowitz et al., 2003 · PubMed (2003) link

Arold et al., 2005 · PubMed (2005) link

Track Alprazolam with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.